Summary
In 20 patients with ischaemic heart disease (IHD), platelet sensitivity to ADP- aggregation,
plasma von Willebrand factor (vWF) and plasma β-thromboglobulin (β-TG) were measured
before and after isometric exercise. Effect of dipyridamole on these determinants
was studied in a crossover fashion. To assess plasma vWF level, a new simple method
was employed which has the advantage of not requiring an optical aggregometer and
was proved to be reproducible.
No significant difference was seen in platelet sensitivity to ADP-aggregation, vWF
and β-TG among healthy controls, IHD patients on placebo and on dipyridamole at rest.
After exercise, platelet sensitivity to aggregation, plasma vWF and β-TG increased
significantly in IHD patients on placebo. In healthy controls, no significant changes
were seen. On dipyridamole, above changes seen in IHD patients were not seen.
The results suggests that isometric exercise may induce platelet release reaction
in vivo and may produce hypercoagulable state in IHD patients. These phenomena may
be prevented by pretreatment with dipyridamole.
